Functional monitoring of anthracycline cardiotoxicity:a prospective, blinded, long-term observational study of outcome in 120 patients
Benny Vittrup Jensen(Gentofte Hospital), Stig Lønberg Nielsen(University of Southern Denmark), Torben Skovsgaard(Unknown)
Cited by 337
Related Papers
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
|Cancer Epidemiology Biomarkers & Prevention|2006|364
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
|Journal of Clinical Oncology|1998|285
Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal Cancer
|Cancer Research|2011|203
New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients
|JNCI Journal of the National Cancer Institute|2008|176
Cellular resistance to anthracyclines
|General Pharmacology The Vascular System|1996|167